Feed ROIV
RO
Roivant Sciences
ROIV · NASDAQ
$35.78 -0.36% (-$0.13)
1M +3.68%
Market Cap $25.8B
P/E Ratio -
Div. Yield -
ROE 8.05%
Bulios Fair Price
$31.22
12.7% downside
Preț actual
$35.78
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile ROIV sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
13 /100
Expensive P/S 1,271.47x
P/B 5.93x
P/E N/A
Growth
22 /100
Declining Rev. growth 36.01%
Book val. growth 57.55%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 89.61%
FCF margin 3,858.45%
Net margin 1,839.58%
Quality
0 /100
Poor ROIC 24.25%
Asset turnover 0.00x
ROE 8.05%
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 33.71x
Int. coverage N/A
Stability
21 /100
Unstable Beta 1.11x
Profitable years 0
Rev. volatility 39.88%
Întreabă StockBot despre ROIV
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Matthew Gline
Employees
721
Headquarters
London
Evenimente viitoare
09 NOV.
Earnings
Upcoming earnings report